Go offline with the Player FM app!
EPISODE #173: What's Wrong With The Cannabis Industry? with Dr. Ethan Russo, Founder of Credo Science
Manage episode 345195216 series 2522512
What’s wrong with the cannabis industry?
Joining us again on the latest episode of The Cannabis Conversation is Dr Ethan Russo, Founder of Credo Science - a novel medical science company.
We discuss the prejudice and ignorance against Cannabis, as well as safety monitoring, legalisation and some of the challenges the industry is facing, including a lack of proper funded research in the area.
The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.
Get in touch at www.luminorecruit.com/
About Ethan Russo
Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Founder/CEO of CReDO Science https://credo-science.com
He is also Medical Director of Andira Pharmaceuticals Andira – Bringing Healing to Life and Senior Medical Advisor to Canurta Home | Canurta
Previously he was Director of Research and Development for the International Cannabis and Cannabinoids Institute, 2017-19, Medical Director of PHYTECS, 2015-2017, and from 2003-2014, Senior Medical Advisor, medical monitor/study physician to GW Pharmaceuticals for numerous Phase I-III clinical trials of Sativex® and Epidiolex®.
He was a clinical neurologist in Missoula, Montana for 20 years. He has held faculty appointments in Pharmaceutical Sciences at the University of Montana, and in Medicine at the University of Washington. He is author/editor of seven books and has published more than 50 peer-reviewed articles.
Resources
Join Dr. Russo on LinkedIn: https://www.linkedin.com/in/ethan-russo-md-468b19a/
View Dr. Russo’s clinical research papers: https://www.researchgate.net/profile/Ethan_Russo
CReDO Science Website: https://credo-science.com/
194 episodes
Manage episode 345195216 series 2522512
What’s wrong with the cannabis industry?
Joining us again on the latest episode of The Cannabis Conversation is Dr Ethan Russo, Founder of Credo Science - a novel medical science company.
We discuss the prejudice and ignorance against Cannabis, as well as safety monitoring, legalisation and some of the challenges the industry is facing, including a lack of proper funded research in the area.
The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.
Get in touch at www.luminorecruit.com/
About Ethan Russo
Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Founder/CEO of CReDO Science https://credo-science.com
He is also Medical Director of Andira Pharmaceuticals Andira – Bringing Healing to Life and Senior Medical Advisor to Canurta Home | Canurta
Previously he was Director of Research and Development for the International Cannabis and Cannabinoids Institute, 2017-19, Medical Director of PHYTECS, 2015-2017, and from 2003-2014, Senior Medical Advisor, medical monitor/study physician to GW Pharmaceuticals for numerous Phase I-III clinical trials of Sativex® and Epidiolex®.
He was a clinical neurologist in Missoula, Montana for 20 years. He has held faculty appointments in Pharmaceutical Sciences at the University of Montana, and in Medicine at the University of Washington. He is author/editor of seven books and has published more than 50 peer-reviewed articles.
Resources
Join Dr. Russo on LinkedIn: https://www.linkedin.com/in/ethan-russo-md-468b19a/
View Dr. Russo’s clinical research papers: https://www.researchgate.net/profile/Ethan_Russo
CReDO Science Website: https://credo-science.com/
194 episodes
همه قسمت ها
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.